pargyline has been researched along with 1-methyl-4-phenylpyridinium in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (66.67) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debler, EA; Hashim, A; Lajtha, A; Reith, ME; Sershen, H | 1 |
| Ambrosio, S; Mahy, N | 1 |
| Harik, SI; LaManna, JC; Riachi, NJ | 1 |
| Kass, GE; Nicotera, P; Orrenius, S; Wright, JM | 1 |
| Weight, FF; Wilson, JA; Wilson, JS | 1 |
| Galvan, M; Kupsch, A; ten Bruggencate, G | 1 |
| Cheeseman, AJ; Clark, JB | 1 |
| Di Monte, D; Ekström, G; Jewell, SA; Sandy, MS; Smith, MT | 1 |
| Jonsson, G; Luthman, J | 1 |
| Irwin, I; Kunis, DM; Langston, JW; Ransom, BR | 1 |
| Irwin, I; Langston, JW | 1 |
| Barbeau, A; Boyer, H; Buu, NT; Dallaire, L; de Lanney, LE; Irwin, I; Langston, EB; Langston, JW; Veilleux, F | 1 |
| Barbeau, A; Buu, NT; Dallaire, L; Poirier, J; Rucinska, E | 1 |
| Altagracia, M; Bravo-Velazquez, S; Kravzov, J; Ríos, C | 1 |
| Griffiths, H; Lai, M; Lunec, J; Pall, H; Williams, A | 1 |
| Akiyama, A; Nakazato, T | 1 |
| Awaya, T; Chiba, K; Hayase, N; Kimura, K; Matsubara, K; Ogawa, S; Senda, T; Shimizu, K; Uezono, T | 1 |
| Barc, S; Barrier, L; Fauconneau, B; Huguet, F; Page, G | 1 |
18 other study(ies) available for pargyline and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Carrier-mediated efflux of [3H]dopamine and [3H]1-methyl-4-phenylpyridine: effect of ascorbic acid.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Ascorbic Acid; Corpus Striatum; Diffusion; Dopamine; In Vitro Techniques; Kinetics; Mice; Mice, Inbred BALB C; Monoamine Oxidase; Pargyline; Reserpine; Synaptosomes | 1991 |
Acute peripheral catecholaminergic changes in rat after MPTP and MPP+ treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Heart; Male; Myocardium; Norepinephrine; Pargyline; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tyrosine 3-Monooxygenase | 1989 |
Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Blood-Brain Barrier; Brain; Butanols; Male; Pargyline; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tritium | 1989 |
The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Calcium; Calcium-Transporting ATPases; Cell Membrane; Cell Membrane Permeability; Cell Survival; Cytosol; Liver; Male; Mitochondria; Monoamine Oxidase Inhibitors; Pargyline; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Selegiline | 1988 |
MPTP causes a non-reversible depression of synaptic transmission in mouse neostriatal brain slice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Corpus Striatum; Dopamine Antagonists; Electric Stimulation; In Vitro Techniques; Mice; Mice, Inbred C57BL; Neural Inhibition; Pargyline; Piperazines; Pyridines; Pyridinium Compounds; Synapses; Synaptic Transmission | 1986 |
Actions of MPTP and MPP+ on synaptic transmission in guinea-pig hippocampal slices.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Evoked Potentials; Female; Guinea Pigs; Hippocampus; In Vitro Techniques; Membrane Potentials; Neurotoxins; Pargyline; Pyridines; Pyridinium Compounds; Synaptic Transmission | 1987 |
Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetylcholine; Allylamine; Animals; Brain; Citric Acid Cycle; Diencephalon; Glucose; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; NAD(P)H Dehydrogenase (Quinone); Pargyline; Pyridines; Pyridinium Compounds; Quinone Reductases; Rats; Rats, Inbred Strains; Synaptosomes; Telencephalon | 1987 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adenosine Triphosphate; Animals; Carmustine; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; In Vitro Techniques; Liver; Male; Pargyline; Pyridines; Pyridinium Compounds; Rats; Time Factors | 1986 |
Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenergic Fibers; Animals; Biological Transport, Active; Desipramine; Heart; Iris; Male; Mice; Nerve Degeneration; Norepinephrine; Pargyline; Pyridines; Pyridinium Compounds | 1986 |
Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Mice; Pargyline; Pyridines; Pyridinium Compounds | 1987 |
Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain Chemistry; Male; Pargyline; Pyridines; Pyridinium Compounds; Saimiri; Substantia Nigra; Tissue Distribution | 1985 |
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain Chemistry; Catechol O-Methyltransferase Inhibitors; Catecholamines; Disease Models, Animal; Melanophores; Motor Activity; Movement; Pargyline; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Pyrogallol; Ranidae; Reflex; Salamandridae; Skin Pigmentation | 1985 |
Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenal Medulla; Animals; Behavior, Animal; Brain Chemistry; Dopamine; Drug Interactions; Epinephrine; Melanophores; Motor Activity; Norepinephrine; Paraquat; Pargyline; Parkinson Disease, Secondary; Pigmentation; Posture; Pyridines; Pyridinium Compounds; Rana pipiens; Reflex | 1985 |
Enhancement of striatal lipid peroxidation induced by 1-methyl-4-phenylpyridinium in mouse brain is blocked by MAO-B inhibitors.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Clorgyline; Lipid Peroxidation; Male; Mice; Monoamine Oxidase Inhibitors; Neostriatum; Pargyline; Selegiline | 1994 |
An investigation into the role of reactive oxygen species in the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity using neuronal cell lines.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Catalase; Cell Death; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Lipid Peroxides; MPTP Poisoning; Neurons; Pargyline; Rats; Reactive Oxygen Species; Selegiline; Superoxide Dismutase; Tumor Cells, Cultured | 1993 |
Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Electrochemistry; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Pargyline; Rats; Rats, Wistar | 1998 |
L-Deprenyl prevents the cell hypoxia induced by dopaminergic neurotoxins, MPP(+) and beta-carbolinium: a microdialysis study in rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carbolines; Cell Hypoxia; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Herbicides; Lactic Acid; Male; Microdialysis; Mitochondria; Monoamine Oxidase Inhibitors; Neostriatum; Neurons; Neuroprotective Agents; Neurotoxins; Pargyline; Parkinson Disease; Rats; Rats, Wistar; Selegiline | 2001 |
Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Tocopherol; Animals; Antioxidants; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; Pargyline; Rats; Rats, Wistar; Substantia Nigra; Synaptosomes; Time Factors; Tocopherols | 2002 |